Drug Topics
AUGUST 1, 2023
How many different ways can analytics assist your pharmacy? More than you may think. Mehrdad Hariri, RPh, CPh, MBA presented a session at July's Total Pharmacy Solution Summit on all the ways you can leverage those data for success.
Pharmacy Times
AUGUST 4, 2023
Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Thyroid Pharmacist
AUGUST 4, 2023
You may have heard of the term “MTHFR gene mutation” and may be wondering what it is. First, I’d like to say that I prefer the term “MTHFR gene variation” rather than “mutation.” The word mutation makes it sound like there’s something wrong with the person, while variation is more empowering – and in my opinion, also more accurate. While the word “mutation” implies an occurrence that is rare, unnatural, or flawed, the MTHFR gene variation is common.
Fierce Healthcare
AUGUST 4, 2023
A silent and grossly underserved epidemic of loneliness is affecting 60% of all America | Numerous experts have called attention to our loneliness epidemic, describing its negative health impact as similar to “smoking 15 cigarettes a day.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
AUGUST 4, 2023
A 510(k) clearance, or a Premarket Notification, requires device manufacturers to notify the FDA at least 90 days ahead of registration with their intent to market a medical device.
Pharmacy Times
AUGUST 4, 2023
CDC Advisory Committee on Immunization Practices voted 10 to 0 to recommend the routine use of nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
AUGUST 4, 2023
State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.< | State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.
Drug Topics
AUGUST 1, 2023
Hear the pharmacists from Eden Drug, Hazel Green, and Professional Pharmacy on their reactions to being a finalist for this award and more.
Pharmacy Times
JULY 31, 2023
Patients with HIV can donate a kidney to others with HIV who have a low risk of developing end-stage renal disease or other kidney problems for 2 to 4 years following donation.
Drug Store News
AUGUST 4, 2023
The donation will help provide more than 9,000 bags of food to be distributed to preschool and elementary children, designed to replace food that those kids would normally have received at school.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
AUGUST 4, 2023
Early-stage cancer diagnoses decreased by nearly 20% in the first year of the Covid-19 pandemic. A new study published in Lancet Oncology emphasizes how, because of disruptions in care, patients were more likely to get diagnosed with deadly metastatic disease — across nearly all cancer types. This study is the most comprehensive analysis of cancer diagnoses during the pandemic, using a nationwide registry that captures over 70% of all cancers in the United States.
Drug Topics
AUGUST 4, 2023
Nearly 25% of people “have vitamin D blood levels that are too low or inadequate for bone and overall health,” according to the NIH.
Pharmacy Times
AUGUST 2, 2023
Study findings contrast with previously reported research linking aspirin to the secondary prevention of stroke, and are especially notable for older adults who may be more susceptible to bleeding-inducing events.
Fierce Healthcare
AUGUST 4, 2023
LGBTQ+ adults are less likely than cisgender, heterosexual adults to have had health screenings in the past year and are more likely to have skipped care, a new survey has found. | In the past year, 25% of LGBTQ+ adults did not have any health screenings, compared to 20% of cisgender, heterosexual adults.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
AUGUST 4, 2023
The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April. The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million.
Drug Topics
AUGUST 1, 2023
Afoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Pharmacy Times
AUGUST 1, 2023
A new study revealed multiple locations across the southeast, including Georgia, Kentucky, and Florida, with areas that had high HIV risk but little-to-no preexposure prophylaxis services in the area.
Fierce Pharma
AUGUST 3, 2023
Even as Moderna chugs through another post-pandemic year, the biotech has raised its COVID-19 vaccine revenue projection in the expectation that it can deliver a strong showing in the private marke | The company raised its forecast for COVID-19 sales to between $6 billion and $8 billion, up from a prior estimate of $5 billion. Elsewhere, an RSV clash with pharma giants nears.
STAT
AUGUST 3, 2023
WASHINGTON — An already record-setting summer heat wave will continue through August and will put more than 51 million Americans at risk of health impacts, according to new data from federal health officials. Most of those vulnerable people live in 26 states and are expected to have at least five extreme heat days this month. Among the highest-risk counties, roughly 45% have high levels of uninsured adults and children and 18% have high senior populations, according to a relatively new mo
Drug Topics
AUGUST 1, 2023
A Q&A with Marc Ost, co-owner of Eric’s RX Shoppe, which was one of the first community pharmacies to receive the new vaccine.
Pharmacy Times
AUGUST 1, 2023
Dostarlimab-gxly (Jemperli) approved in combination with carboplatin and paclitaxel for the treatment of adults with primary advanced or recurrent endometrial cancer that is mismatch repair deficient.
Fierce Healthcare
AUGUST 3, 2023
Scripta Insights, a digital health company focused on pharmacy navigation, is teaming up with Mark Cuban Cost Plus Drug Company to bring transparent drug pricing to patients. | Scripta will integrate Cost Plus Drugs’ discounted pricing into its platform to help members understand their medication options.
STAT
AUGUST 3, 2023
New research that combines technology to sequence “ancient DNA” with direct-to-consumer genetic testing has identified tens of thousands people alive today who are genetically linked to enslaved and free African Americans who worked at a once-thriving Maryland iron forge in the late 18th and early 19th century. The findings, reported Thursday in Science , are a step toward restoring difficult-to-obtain ancestry knowledge to African Americans who descended from enslaved people, whos
Drug Topics
AUGUST 2, 2023
Moderna’s mRNA-1273 vaccine was associated with a lower risk of diagnosed COVID-19 when compared to Pfizer’s BNT162b2.
Pharmacy Times
AUGUST 2, 2023
The study authors said that, to their knowledge, this will be the first systemic review focusing on the effects of cognitive interventions for those with chronic respiratory diseases.
Fierce Healthcare
AUGUST 3, 2023
This week, enforcement of San Diego’s new homeless encampment ba | Street medicine entails delivering medical care to those without housing or living in poverty, whether on the streets or in shelters. Such programs have been shown to provide significant cost savings and be a cost-effective way to improve health outcomes and reduce disparities in underserved populations—particularly as Medicaid redeterminations threaten many individuals' access to care.
STAT
AUGUST 3, 2023
Patients are bracing for “D-Day,” the date their insurance companies will stop covering the drugs. Doctors are getting letters from insurance investigators discouraging new prescriptions. And pharmacies are being told by insurers to check for a specific diagnosis when filling prescriptions. It’s a charge on all fronts by insurance companies to contain the spiraling costs of a new class of weight loss-inducing drugs, the GLP-1s.
Drug Topics
AUGUST 3, 2023
A study found that patients achieved 50% improvement with JAK inhibitors compared to placebo.
Pharmacy Times
JULY 31, 2023
Pharmacists are critically important in care delivery in their ability to influence patient success, patient-reported outcomes, and quality of life while reducing the burden on physicians and their clinical support teams.
Fierce Pharma
AUGUST 3, 2023
As Novo Nordisk and Eli Lilly rack up significant sales from their GLP-1 diabetes and obesity drugs, the companies also must gear up for defense against lawsuits from new users. | A Louisiana woman is suing Novo Nordisk and Eli Lilly, alleging that her use of Ozempic and Mounjaro caused her to vomit so much that some of her teeth have fallen out. Jaclyn Bjorklund, 44, says that she also has been hospitalized on "several" occasions and that the companies failed to warn patients of “seve
STAT
AUGUST 3, 2023
The early warning disease network that alerted the world to the original SARS outbreak and the start of the Covid-19 pandemic appears to be in peril. A number of the senior moderators of ProMED-mail, a program operated by the International Society of Infectious Diseases, posted a letter of protest early Thursday, challenging a recently revealed plan to charge for subscriptions to the service.
The Checkup by Singlecare
AUGUST 3, 2023
What is weight loss ? | How common is weight loss? | Weight loss stats in the U.S. | Weight loss stats by sex | Weight loss statistics by race | Weight loss statistics by age | Weight loss stats by weight status | Weight loss and overall health | Costs | Reasons for weight loss | Treatment | FAQs | Research Weight loss can have health benefits for people who have a high body mass index ( BMI ) or obesity.
Pharmacy Times
AUGUST 2, 2023
Study investigators observed no significant differences in oxygen supplementation, hospitalization, or COVID-19 related death between initiators and non-initiators, though they cautioned more research was needed.
European Pharmaceutical Review
AUGUST 3, 2023
The Danish Medicines Agency (Lægemiddelstyrelsen) has announced the European Pharmacopoeia Commission has adopted a new European monograph, which describes quality requirements for the raw material Cannabis flower. EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5.
Expert insights. Personalized for you.
187 
Let's personalize your content